Respuesta carta al editor

Oliveira, AC, Alves Da Silva AV, Marclesson Alves EC, Cronemberger E, Carneiro B, Melo JC, et al. Molecular células não pequenas no Nordeste brasileiro. J. bras. pneumol ; 45(3): e20180181, 2019. tab, grafGelatti ACZ. https://doi.org/10.1590/1806-3713/e20180181

Gelatti AC, Cordeiro de Lima VC, Freitas H, Werutsky G, Gaiger AM , Klock C et al. Real-World Prevalence of PD-L1. Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer. Clin. Lung Cancer. 2020 Nov;21(6):e511-e515. https://doi.org/10.1016/j.cllc.2020.04.007

Arrieta O, Cardona AF , Bramuglia G, Cruz-Rico G, Corrales L, Martín C et al. On behalf of the CLICaP. Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America. Oncology. 2019;96(4):207-216. https://doi.org/1159/000493733

Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY , Cronin KA et al. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020 Aug 13;383(7):640-649. https://doi.org/10.1056/NEJMoa1916623

Nicholas J, Esmond R, Nwokeji D, Janet L, Espirito S, Chen L, et al. Evangelist, Biomarker tissue journey among patients (pts) with untreated metastatic non-small cell lung cancer (mNSCLC) in the U.S. Oncology Network community practices. ASCO 2021, Volume 39, Issue 15_suppl.

Charvel S, Cobo-Armijo F, Hernández-Ávila M, Reynales-Shigematsu L M, Salas, J, Arrieta O, et al. Needs in coverage and care for lung cancer in Mexico. Salud Publica Mex. May-Jun 2019;61(3):339-346. https://doi.org/10.21149/10114.234